The Immune Response of Cancer Cells in Breast and Gynecologic Neoplasms
Open Access
- 5 June 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 6206
Abstract
Cancer diseases constitute a major health problem which leads to the death of millions of people annually. They are unique among other diseases because cancer cells can perfectly adapt to the environment that they create themselves. This environment is usually highly hostile and for normal cells it would be hugely difficult to survive, however neoplastic cells not only can survive but also manage to proliferate. One of the reasons is that they can alter immunological pathways which allow them to be flexible and change their phenotype to the one needed in specific conditions. The aim of this paper is to describe some of these immunological pathways that play significant roles in gynecologic neoplasms as well as review recent research in this field. It is of high importance to possess extensive knowledge about these processes, as greater understanding leads to creating more specialized therapies which may prove highly effective in the future.Keywords
Funding Information
- Statutory Subsidy Funds of the Department of Molecular and Cellular Biology (SUBZ.D260.24.076)
This publication has 167 references indexed in Scilit:
- Revisiting the role of endogenous STAT3 in HPV‐positive cervical cancer cellsJournal of Medical Virology, 2023
- STAT3 pathway in cancers: Past, present, and futureMedcomm, 2022
- The ever‐increasing importance of cancer as a leading cause of premature death worldwideCancer, 2021
- Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic targetMedical Oncology, 2020
- Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiationCancer Immunology, Immunotherapy, 2019
- Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axisCancer Medicine, 2019
- Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patientsClinical and Translational Oncology, 2017
- The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cellsThe Prostate, 2006
- ANNEXIN I IS STORED WITHIN GELATINASE GRANULES OF HUMAN NEUTROPHIL AND MOBILIZED ON THE CELL SURFACE UPON ADHESION BUT NOT PHAGOCYTOSISCell Biology International, 2000
- Lipocortin-1: cellular mechanisms and clinical relevanceTrends in Pharmacological Sciences, 1994